The Federal Government's 2015-16 Budget announcements benefit research
The Federal Government’s 2015-16 Budget was announced this week with a boost for medical research funding. The new funding is expected to save lives and help thousands of Australians, especially those living with melanoma. Hopefully this will ensure more government support over the next few years for MIA research.
The Government will distribute more than $400 million from the Medical Research Future Fund (MRFF) for health and medical research over the next four years, beginning with an initial disbursement of $10 million in 2015-16.
The MRFF fund has come at the best time to deliver renewed confidence to the health and medical research sector. Within a decade there will be a doubling of funding for medical research via a safe-guarded future fund while giving some immediate relief through an initial $10 million disbursement, and another $407 million to come.
“With an ageing population and more than seven million Australians already living with chronic illnesses such as cardiovascular disease, cancer and mental health issues, we cannot afford not to invest in health and medical research to find new ways to diagnose, treat and prevent these debilitating diseases,” said Association of Australian Medical Research Institutes (AAMRI) President, Professor Doug Hilton.
Professor Hilton said that health and medical research supported by the MRFF would not only improve life expectancy and quality of life for Australians, it would also deliver financial returns to the nation.
“Every dollar invested in health and medical research generates more than two dollars in health and productivity gains by reducing the burden of disease on the health system and productivity, and through the creation of new innovative businesses and jobs in the health industry,” he said.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.